Biotech Growth Share Price (BIOG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Biotech Growth Trust (the) Plc	LSE:BIOG	London	Ordinary Share	GB0000385517	ORD 25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+8.00p	+1.13%	718.00p	122,023	16:35:07

Bid Price		Offer Price	High Price	Low Price	Open Price
710.00p		716.00p	716.00p	706.00p	710.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Equity Investment Instruments	1.58	0.84	1.10	652.7	373.1

Related Shares
Scottish Mortgage Invest... (SMT), Etfs Phy Pm B � (PHPP), Energiser Investments (ENGI), Tiger Resource (TIR)

Biotech Growth (BIOG) Latest News (3)

Biotech Growth News

Date	Time	Source	Headline
17/5/2019	14:39	PRNUS	The Biotech Growth Trust Plc - Monthly Fact Sheet as at 30 April 2019
01/5/2019	07:59	UKREG	Biotech Grw Tst PLC Total Voting Rights
01/5/2019	07:58	PRNUS	The Biotech Growth Trust Plc - Total Voting Rights
23/4/2019	09:42	PRNUS	The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation
18/4/2019	17:04	PRNUS	The Biotech Growth Trust Plc - Transaction in Own Shares
17/4/2019	14:36	PRNUS	The Biotech Growth Trust Plc - Net Asset Value(s)
16/4/2019	13:00	UKREG	Biotech Grw Tst PLC Net Asset Value(s)

More Biotech Growth News

Biotech Growth Takeover Rumours

Biotech Growth (BIOG) Share Charts

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

Intraday Biotech Growth Chart

Biotech Growth (BIOG) Discussions and Chat

Biotech Growth Forums and Chat

Date	Time	Title	Posts
09/5/2019	20:29	Biotech Growth Trust PLC (The)	303

Add a New Thread

Biotech Growth (BIOG) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Biotech Growth trades in real-time

Biotech Growth (BIOG) Top Chat Posts

Date	Subject
19/5/2019 09:20	Biotech Growth Daily Update: Biotech Growth Trust (the) Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth was 710p. Biotech Growth Trust (the) Plc has a 4 week average price of 668p and a 12 week average price of 668p. The 1 year high share price is 854p while the 1 year low share price is currently 596p. There are currently 51,967,562 shares in issue and the average daily traded volume is 238,629 shares. The market capitalisation of Biotech Growth Trust (the) Plc is £373,127,095.16. Read Full Thread Reply
04/4/2018 00:56	andyj: Share price nearly 10% below NAV now, should see some buy backs. Read Full Thread Follow Reply
22/11/2014 20:58	philo124: Just read their Report and Accounts; not sure I should have sold even at these levels- looks like the story and share price has further to go in 2015. Read Full Thread Follow Reply
10/4/2014 13:26	urgentclick: Looks good to me: downside recently around 409p (I picked up 1000 at that price point) and upside 550p not long ago. And the NAV comfortably exceeding the share price. Read Full Thread Follow Reply
14/1/2013 00:50	yiyack3: In my experience many AIM companies are pretty well worthless, run by a CEO and a crony or two who like the good life, first class on expenses, get rich as quick as poss and don't worry when the company runs out of cash, goes bust and all the shareholders lose their investments. If an AIM company gets to be popular on the ADVFN and other bulletin boards, do what you can to hitch a ride on rising share price, then take profits and get out. Don't ever believe the story behind an AIM market share Read Full Thread Follow Reply
29/7/2012 20:24	northernlass: THE QUARTER'S BEST PERFORMER Looking at individual investment portfolios, the Biotech Growth trust was the quarter's best performer in terms of both net asset value (NAV) and share price. Over the three months, its NAV rose 19.1% while share price was up 11.4% on a total return basis. Source: http://www.fundweb.co.uk/investment-trusts/news/trusts-ahead-of-open-ended-peers-despite-q2-underperformance/1053944.article Read Full Thread Follow Reply
21/7/2010 18:33	chingman: Latest from Edison - The Biotech Growth Trust Plc (BIOG) has put in a respectable performance during the past 12 months, outperforming its benchmark, the NASDAQ Biotechnology Index (sterling adjusted), by 2.8% in terms of NAV total return and 3.9% in terms of share price total return. The manager believes that concerns over US healthcare reform were overdone and, while this cloud of uncertainty has lifted, concerns regarding the outlook in Europe have delayed the reversion. Looking forward, the manager considers that; biotech will be a net beneficiary of healthcare reform; the regulatory environment will continue to improve; M Read Full Thread Follow Reply
26/1/2010 19:28	damanko: Ian - two is a crowd ............... I didn't bother participating in the recent fund raising, as the amount payable (ie the stated NAV) was some way north of the share price. In fact, I meant to write to the board, and ask who on earth would bother (amongst longer term holders) - when this was the case. Whatever, the institutions were keen, and the price has carried on its mild upward trend. Worth tucking away. Mind you, having bought about nine years ago, I'm now only 25% or so down on what I paid. Ho hum.... Read Full Thread Follow Reply

Biotech Growth share price data is direct from the London Stock Exchange

Your Recent History

LSE

BIOG

Biotech Gr..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190519 19:03:31